Short-term loop diuretic withdrawal in optimized heart failure with diabetes: A pilot randomized study integrating POCUS and NT-proBNP for congestion monitoring

Introduction: Loop diuretics (LD) are central in the management of heart failure (HF) congestion. However, prolonged use may contribute to poor outcomes and adverse events. Evidence supporting safe withdrawal of LD and appropriate patient selection among ambulatory HF patients with type 2 diabetes mellitus (T2DM) remains limited. We evaluated the safety of LD withdrawal, utilizing multiparametric congestion monitoring, and factors associated with congestion development in such patients. Methods: Sixty ambulatory HF patients with T2DM were randomized to either continuation or withdrawal of LD, in our open-label pilot study. Participants underwent assessment for congestion (subclinical and clinical) using a multiparametric approach, including lung ultrasound, venous excess ultrasound, N-terminal pro–B-type natriuretic peptide (NT-proBNP), and six-minute walk test. Results: In this study, 35.0% of participants developed congestion (31.7% subclinical and 15.0% clinical). There were no significant differences for subclinical (36.7% vs 26.7%; p=0.405), clinical (20.0% vs 10.0%; p=0.278), or composite congestion (43.4% vs 26.7%; p=0.176) between both study arms. Abnormal hepatic vein Doppler patterns (possibly suggestive of subclinical congestion) were more frequent in the LD withdrawal arm (16.7% vs 0.0%; p=0.020). Elevated baseline NT-proBNP was independently associated with subclinical (odds ratio [OR] 1.448; p=0.008), clinical (OR 1.737; p<0.001) and composite congestion (OR 1.480; p=0.015) in exploratory multivariable analyses. Conclusion: In this pilot open-label study, short-term loop diuretic withdrawal in carefully selected, clinically euvolemic ambulatory HF patients with T2DM, was feasible and not associated with a statistically significant excess of clinical or subclinical congestion over 4 weeks. These findings require confirmation in larger, adequately powered multicentre trials with longer follow-up and clinical outcomes.

Authors

Institutions

Publication Details

Journal
The Ultrasound Journal
Published
2026-11-20
DOI
https://doi.org/10.5826/tuj.2026.19594
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Short-term loop diuretic withdrawal in optimized heart failure with diabetes: A pilot randomized study integrating POCUS and NT-proBNP for congestion monitoring

Norashikin Saidon, Mohamad Rodi Isa, Azrain Amri Mohd Farid, Raja Ezman Raja Shariff et al.
The Ultrasound Journal
Heart Failure Treatment and Management
article

Short-term loop diuretic withdrawal in optimized heart failure with diabetes: A pilot randomized study integrating POCUS and NT-proBNP for congestion monitoring

Norashikin Saidon, Mohamad Rodi Isa, Azrain Amri Mohd Farid, Raja Ezman Raja Shariff, Julina Md Noor
article en

Abstract

Introduction: Loop diuretics (LD) are central in the management of heart failure (HF) congestion. However, prolonged use may contribute to poor outcomes and adverse events. Evidence supporting safe withdrawal of LD and appropriate patient selection among ambulatory HF patients with type 2 diabetes mellitus (T2DM) remains limited. We evaluated the safety of LD withdrawal, utilizing multiparametric congestion monitoring, and factors associated with congestion development in such patients. Methods: Sixty ambulatory HF patients with T2DM were randomized to either continuation or withdrawal of LD, in our open-label pilot study. Participants underwent assessment for congestion (subclinical and clinical) using a multiparametric approach, including lung ultrasound, venous excess ultrasound, N-terminal pro–B-type natriuretic peptide (NT-proBNP), and six-minute walk test. Results: In this study, 35.0% of participants developed congestion (31.7% subclinical and 15.0% clinical). There were no significant differences for subclinical (36.7% vs 26.7%; p=0.405), clinical (20.0% vs 10.0%; p=0.278), or composite congestion (43.4% vs 26.7%; p=0.176) between both study arms. Abnormal hepatic vein Doppler patterns (possibly suggestive of subclinical congestion) were more frequent in the LD withdrawal arm (16.7% vs 0.0%; p=0.020). Elevated baseline NT-proBNP was independently associated with subclinical (odds ratio [OR] 1.448; p=0.008), clinical (OR 1.737; p<0.001) and composite congestion (OR 1.480; p=0.015) in exploratory multivariable analyses. Conclusion: In this pilot open-label study, short-term loop diuretic withdrawal in carefully selected, clinically euvolemic ambulatory HF patients with T2DM, was feasible and not associated with a statistically significant excess of clinical or subclinical congestion over 4 weeks. These findings require confirmation in larger, adequately powered multicentre trials with longer follow-up and clinical outcomes.

The Ultrasound JournalVol. 18(1)
Universiti Teknologi MARA (MY)
Universiti Teknologi MARA
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon